AKLI

A Chewy Insight on Akili Inc's Stock Stock valuation can sometimes feel like practicing alchemy, but not when we're dealing with Akili, Inc. As we decode the company's Q3 2023 balance sheet, plain old numbers transform into an exhilarating treasure hunt. Starting with a glance at total assets, we stand at $931.42 million USD, heavily propped up by a lip-smacking $86.28 million USD in cash. Now that’s a bountiful war chest for a company operating in the volatile healthcare industry (SIC Code: 3841)! Gifted with the ability to spot hidden shadows, we're intrigued by the dark horse in the form of $37.50 million USD – the net cash flow from investing activities. Remember folks, this figure represents money spent or received from investments – everything from acquisitions and investments in joint ventures to sales of property and equipment. In Akili's case, the number's high, hinting at a bullish strategy. Hmmm, do I hear some grumbles about the $15.88 million USD net loss? Hold on to your calculators, because these numbers need context, or they're as much use as a chocolate teapot! Check out the selling, general, and administrative expenses that tip the scales at $13.94 million USD. And don't ignore the $4.91 million USD in research and development costs. Yes, these are part of the operating expenses. And yes, they’re high, but remember, tech-heavy firms like Akili are not afraid to shell out a fortune to stay ahead in the game. Equity, Akili's self-worth if you like, is sitting pretty at $69.09 million USD. Akili's leverage ratio (liabilities/equity), is approximately 0.35. For a healthcare firm, this is a robust number showing the firm is not overly burdened by debt. Huh, a quick peek at the income statement shows the diluted earnings per share at a -0.20 USD from 78,217,870 diluted average shares. Now, don't get your tail feathers ruffled! Remember, negative EPS is not unusual for companies investing heavily in growth. At a loss regarding the net operating cash flow? Dangling at -$18.045 million USD, it may seem a bit of a head-scratcher, but go easy on those grumbles. Cash might be king, but here context wears the crown. Consider the economic environment, interest rates, currency fluctuations and that little thing called an ongoing pandemic! Do you see why stock investing isn't for the fainthearted? It's a roller coaster that can twist, turn and head south quicker than a peregrine falcon diving for dinner. But then, isn't that all part of the fun, at least when you're peering into the financial soul of Akili Inc?